Matinas BioPharma Holdings, Inc. MTNB
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.68% | 21.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.68% | 21.00% | |||
| Operating Income | 19.68% | -21.00% | |||
| Income Before Tax | 30.97% | -0.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.97% | -0.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.97% | -0.47% | |||
| EBIT | 19.68% | -21.00% | |||
| EBITDA | 19.33% | -20.74% | |||
| EPS Basic | 30.97% | 1.46% | |||
| Normalized Basic EPS | 19.00% | -2.45% | |||
| EPS Diluted | 30.97% | 1.46% | |||
| Normalized Diluted EPS | 19.00% | -2.45% | |||
| Average Basic Shares Outstanding | 0.00% | 1.96% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||